nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A biomarker for lymphangioleiomyomatosis
|
Kwiatkowski, David |
|
2013 |
1 |
6 |
p. 424-425 2 p. |
artikel |
2 |
Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment
|
Friedrich, Sven O |
|
2013 |
1 |
6 |
p. 462-470 9 p. |
artikel |
3 |
Call for Essays
|
Dehnel, Tim |
|
2013 |
1 |
6 |
p. 444- 1 p. |
artikel |
4 |
Can genes forecast asthma risk?
|
Ege, Markus J |
|
2013 |
1 |
6 |
p. 425-426 2 p. |
artikel |
5 |
Comparison of two methods for acquisition of sputum samples for diagnosis of suspected tuberculosis in smear-negative or sputum-scarce people: a randomised controlled trial
|
Peter, Jonathan G |
|
2013 |
1 |
6 |
p. 471-478 8 p. |
artikel |
6 |
CTPA use reignites debate on overdiagnosis
|
Granovetter, Michael |
|
2013 |
1 |
6 |
p. 436- 1 p. |
artikel |
7 |
Cystic fibrosis: bridging the treatment gap in early childhood
|
Davies, Jane C |
|
2013 |
1 |
6 |
p. 433-434 2 p. |
artikel |
8 |
Exercise performance tests in patients with COPD
|
Yaqub, Farhat |
|
2013 |
1 |
6 |
p. 438- 1 p. |
artikel |
9 |
Inducing sputum or advice from a trained worker: does it make a difference?
|
Cuevas, Luis E |
|
2013 |
1 |
6 |
p. 428-429 2 p. |
artikel |
10 |
Is a qualitative perspective missing from COPD guidelines?
|
Wainwright, Megan |
|
2013 |
1 |
6 |
p. 441-442 2 p. |
artikel |
11 |
NICE and GOLD response
|
Vestbo, Jørgen |
|
2013 |
1 |
6 |
p. 442- 1 p. |
artikel |
12 |
Patient groups drive research for lymphangiomyomatosis
|
Akkermans, Rebecca |
|
2013 |
1 |
6 |
p. 443-444 2 p. |
artikel |
13 |
Political patronage helps fuel southeast Asia's seasonal haze
|
Furlow, Bryant |
|
2013 |
1 |
6 |
p. 435- 1 p. |
artikel |
14 |
Polygenic risk and the development and course of asthma: an analysis of data from a four-decade longitudinal study
|
Belsky, Daniel W |
|
2013 |
1 |
6 |
p. 453-461 9 p. |
artikel |
15 |
Pulmonary hypertension in β thalassaemia
|
Anthi, Anastasia |
|
2013 |
1 |
6 |
p. 488-496 9 p. |
artikel |
16 |
Rare lung disease and orphan drug development
|
Spagnolo, Paolo |
|
2013 |
1 |
6 |
p. 479-487 9 p. |
artikel |
17 |
Regulatory challenges for refined nicotine products
|
Cobb, Nathan K |
|
2013 |
1 |
6 |
p. 431-433 3 p. |
artikel |
18 |
Respiratory infections in early childhood ups diabetes risk
|
Tanday, Sanjay |
|
2013 |
1 |
6 |
p. 438- 1 p. |
artikel |
19 |
Serum VEGF-D concentration as a biomarker of lymphangioleiomyomatosis severity and treatment response: a prospective analysis of the Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus (MILES) trial
|
Young, Lisa R |
|
2013 |
1 |
6 |
p. 445-452 8 p. |
artikel |
20 |
Should e-cigarettes be regulated as a medicinal device?
|
Hajek, Peter |
|
2013 |
1 |
6 |
p. 429-431 3 p. |
artikel |
21 |
The right to health for Syrian refugees
|
Burki, Talha Khan |
|
2013 |
1 |
6 |
p. 439-440 2 p. |
artikel |
22 |
US oncologists seek reversal of chemotherapy cuts
|
Furlow, Bryant |
|
2013 |
1 |
6 |
p. 437- 1 p. |
artikel |
23 |
Victory for a rare alliance
|
The Lancet Respiratory Medicine, |
|
2013 |
1 |
6 |
p. 423- 1 p. |
artikel |
24 |
Xpert MTB/RIF: monitoring response to tuberculosis treatment
|
Nicol, Mark P |
|
2013 |
1 |
6 |
p. 427-428 2 p. |
artikel |